Expand BDTX Menu
BDTX MENU

BDTX Stock Summary and Trading Ideas (Black Diamond Therapeutics | NASDAQ:BDTX)

Charts for Today's Stock Price and Implied Volatility in Black Diamond Therapeutics

Stock Price & Volume | Full Chart

30-Day Implied Volatility | IV30 Full Chart

Trade Ideas for Best Option Strategies for BDTX by Theoretical Edge and Win Rates

Sentiment

Trading Statistics

Key Ratios

Black Diamond Therapeutics (BDTX) Frequently Asked Questions

What does Black Diamond Therapeutics do?

Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.

What symbol and exchange does Black Diamond Therapeutics shares trade?

Black Diamond Therapeutics trades on the NASDAQ stock market under the symbol BDTX.

What is Black Diamond Therapeutics stock price doing today?

As of July 15, 2025, BDTX stock price climbed to $2.95 with 1,120,642 million shares trading.

What is Black Diamond Therapeutics's Beta?

BDTX has a beta of 2.34, meaning it tends to be more sensitive to market movements. BDTX has a correlation of 0.28 to the broad based SPY ETF.

How much is Black Diamond Therapeutics worth?

BDTX has a market cap of $167.74 million. This is considered a Micro Cap stock.

How much money does Black Diamond Therapeutics make?

Last quarter Black Diamond Therapeutics reported $70 million in Revenue and $.98 earnings per share. This beat revenue expectation by $47 million and exceeded earnings estimates by $.88.

What is the highest and lowest price Black Diamond Therapeutics traded in the last 3 year period?

In the last 3 years, BDTX traded as high as $7.66 and as low as $1.18.

What are the top ETFs holding Black Diamond Therapeutics?

The top ETF exchange traded funds that BDTX belongs to (by Net Assets): VTI, VXF, FESM, VTWO, IWC.

Is Black Diamond Therapeutics (BDTX) a good investment?

BDTX has underperformed the market in the last year with a return of -47.8%, while SPY returned +12.4%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in BDTX shares. However, BDTX has outperformed the market in the last 3 month and 2 week periods, returning +110.7% and +19.0%, while SPY returned +15.7% and +0.7%, respectively. This indicates BDTX has been having a stronger performance recently.

What are the support and resistance levels for Black Diamond Therapeutics (BDTX)?

BDTX support price is $2.79 and resistance is $3.09 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that BDTX shares will trade within this expected range on the day.